Head to Head Analysis: ADB International Group (OTCMKTS:EQUR) versus Enovis (NYSE:ENOV)

ADB International Group (OTCMKTS:EQUR) and Enovis (NYSE:ENOV) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Valuation & Earnings

This table compares ADB International Group and Enovis”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADB International Group	N/A	N/A	N/A	N/A	N/A
Enovis	$2.28 billion	0.71	-$1.18 billion	($19.88)	-1.42

ADB International Group has higher earnings, but lower revenue than Enovis.

Institutional and Insider Ownership

98.4% of Enovis shares are held by institutional investors. 79.6% of ADB International Group shares are held by company insiders. Comparatively, 2.9% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ADB International Group and Enovis, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADB International Group	0	0	0	0	0.00
Enovis	1	1	7	1	2.80

Enovis has a consensus price target of $41.86, suggesting a potential upside of 48.39%. Given Enovis’ stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than ADB International Group.

Profitability

This table compares ADB International Group and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADB International Group	N/A	N/A	N/A
Enovis	-49.92%	10.32%	4.57%

Summary

Enovis beats ADB International Group on 8 of the 10 factors compared between the two stocks.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.